• VIDAS® Fertility panel

VIDAS® Fertility panel

Investigation and treatment of infertility

The VIDAS® Fertility panel includes 8 fully
automated hormone tests
 for the quantitative
measurement of luteinizing hormone (LH), follicle-
stimulating hormone (FSH), estradiol, prolactin,
progesterone, testosterone, human chorionic
gonadotropin (hCG) and anti-Müllerian hormone
(AMH)*.

  • Robust and reliable AMH assay*
  • Clinically validated estradiol and progesterone assays
  • Convenient solution for fertility centers to perform on-site testing

 

 

Add to my selection

Do you need more information

The VIDAS® Fertility panel provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia and azoospermia. In assisted reproductive technologies (ART), correct diagnosis of the cause of infertility is a pre-requisite to successful treatment. In addition, our hormone tests are essential monitoring tools in IVF protocols. They contribute to the optimization of individual patient treatment for increased chances of success and greater patient comfort.

Hormone testing in ART

Hormone measurements are essential to personalize treatment of infertility and monitor the progress of ovarian stimulation.

Before treatment, they allow to identify the type of ovulation disorder and know the patient’s ovarian reserve.

During treatment, they are used to check compliance, optimize drug doses, and avoid futile embryo replacements and severe complications.


Hormone assays in the diagnosis and treatment of infertility - Click to enlarge »

 

Reliable and robust AMH assay*

* VIDAS® AMH is not available in the following countries, states and regions: Armenia, Australia, Austria, Azerbaijan, Belarus, Belgium, Canada, Denmark, France, Germany, Hong-Kong, Ireland, Israel, Italy, Japan, Kazakhstan, Kyrgyzstan, Lichtenstein, Moldavia, New Zealand, Portugal, Russia, Spain, Switzerland, Tajikistan, The Netherlands, Turkey, Turkmenistan, United Kingdom.

** See package insert

The new VIDAS® AMH assay* offers on-hand quality testing for confident decisions:

  • Reliable results when compared with an existing automated method**
  • Patented proprietary raw materials for minimal impact of the pre-analytical stage on test results:
    up to 3 freezing/thawing cycles possible

In the context of infertility management, immediate integration of AMH measurements into the full
diagnostic work-up allows to reduce patient stress, avoid unnecessary ovarian stimulation and
reduce the risk of hyperstimulation syndrome.

Precise and sensitive tools

Clinical evaluation of the VIDAS® Estradiol and VIDAS® Progesterone assays has confirmed their reliability for use in evaluating natural cycles and monitoring ovarian superovulation1:

  • Accuracy in the low concentration range to confirm pituitary suppression after GnRH-agonist therapy
  • Strong correlation between serum estradiol measured by VIDAS® Estradiol and follicular measurements by ultrasonography during gonadotropin treatment with both GnRH analogue protocols

 

Testing made simple for fertility clinics

Easy-to-use solution:

  • No need for water
  • All-inclusive reagent kits with ready-to-use reagents
  • Just Load & Go
  • No need for complex training
  • Easy maintenance
  • Robust instrument: MTBF > 700 days

Enables on-site testing for key advantages:

  • Rapid results
  • Faster adaptation of stimulation treatment
  • Cost-effectiveness

Fertility, thyroid and serology testing can be performed on the same instrument:

  • Broad VIDAS® test menu including HIV, hepatitis, toxoplasmosis, rubella, CMV, TSH, FT3, FT4 and Anti-TPO

Notes

* VIDAS® AMH is not available in the following countries, states and regions: Armenia, Australia, Austria, Azerbaijan, Belarus, Belgium, Canada, Denmark, France, Germany, Hong-Kong, Ireland, Israel, Italy, Japan, Kazakhstan, Kyrgyzstan, Lichtenstein, Moldavia, New Zealand, Portugal, Russia, Spain, Switzerland, Tajikistan, The Netherlands, Turkey, Turkmenistan, United Kingdom.

** See package insert

Reference

1. E. Anckaert et al. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment. Clin Chem Lab Med 2002; 40(8):824-831.

 

  VIDAS® Estradiol II VIDAS® FSH VIDAS® HCG VIDAS® LH
Reference 30 431 30 407 30 405 30 406
Tests / kit 60 60 60 60
Sample type Human serum or plasma Human serum or plasma Human serum or plasma Human serum or plasma
Sample volume 200µL 200µL 100µL 200µL

 

  VIDAS® Prolactin VIDAS® Progesterone VIDAS® Testosterone
Reference 30 410 30 409 30 418
Tests / kit 60 60 30
Sample type Human serum or plasma Human serum or plasma Human serum or plasma (on heparin)
Sample volume 200µL 200µL 200µL

 

  VIDAS® Testosterone II

VIDAS® AMH*

Reference 414 320 417 011
Tests / kit 30 30
Sample type Human serum or plasma

Human serum or
plasma (lith. hep.)

Sample volume 100µL 200µL

 

Find more technical details on www.myvidas.com.

Consult your local bioMérieux representative for product availability in your country.

Webcast series | Infertility diagnosis and treatment

Learn more about the unique and essential role of different hormones in fertility with Prof. Johan Smitz, Head of the Hormone Laboratory at the University Hospital in Brussels, and discover how hormone assays can make a key contribution to the successful implementation of ART protocols.

6 episodes are available on myvidas.com:

  • Role of hormones in the menstrual cycle

  • Ovarian stimulation: principles and hormone measurements

  • Importance of progesterone testing during ovarian stimulation

  • Role of LH and E2 in natural cycle monitoring and mild ovarian stimulation

  • Role of LH and E2 in stimulation monitoring for I.V.F or I.C.S.I

  • Anti-Müllerian Hormone: a powerful clinical biomarker in women

Register now!

Useful Links

European Society of Human Reproduction and Embryology (ESHRE)
American Society for Reproductive Medicine (ASRM)

Poster

Cosin P., Auberger F., Blasco P., Blanc J., Baudino G., Dupret-Carruel J., Hausmann M. Development of the VIDAS® Testosterone II assay. IFCC-WorldLab Istanbul 2014.

 

Find more scientific and educational resources on www.myvidas.com.

Pioneering Diagnostics